Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.
Eur J Immunol. 2018 Sep;48(9):1573-1579. doi: 10.1002/eji.201847492. Epub 2018 Jul 30.
Eur J Immunol. 2018.
PMID: 29979809
Free article.